Forte Biosciences, Inc. (FBRX)
30.28
-1.48
(-4.66%)
USD |
NASDAQ |
Mar 05, 16:00
30.32
+0.04
(+0.13%)
Pre-Market: 20:00
Forte Biosciences Total Assets (Quarterly) : 97.09M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.564B |
| Agenus, Inc. | 233.89M |
| Alnylam Pharmaceuticals, Inc. | 5.026B |
| Savara, Inc. | 140.92M |
| Arrowhead Pharmaceuticals, Inc. | 1.604B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 12.99M |
| Shareholders Equity (Quarterly) | 84.10M |
| Current Ratio | 7.344 |